Clover Biopharmaceuticals
0
0
+$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Aug 26Expected
Q2 2024
Q2 2025
Q4 2025
Q2 2026
-0.01
0.32
0.66
0.99
Expected EPS
N/A
Actual EPS
N/A
Financials
-5,912.19%Profit Margin
Unprofitable490,118.02Revenue
-28.98MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Show More
CEO
Joshua G. Liang
Employees
257
Country
China
ISIN
KYG2280A1076
Listings
0 Comments
Share your thoughts
FAQs
What is Clover Biopharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Clover Biopharmaceuticals stocks are traded under the ticker CBPHF.
When is the next Clover Biopharmaceuticals earnings date?▼
Clover Biopharmaceuticals is going to release the next earnings report on March 30, 2027.
What is Clover Biopharmaceuticals revenue for the last year?▼
Clover Biopharmaceuticals revenue for the last year amounts to 490,118.02 USD.
What is Clover Biopharmaceuticals net income for the last year?▼
CBPHF net income for the last year is -28.98M USD.
How many employees does Clover Biopharmaceuticals have?▼
As of November 8, 2026, the company has 257 employees.
In which sector is Clover Biopharmaceuticals located?▼
Clover Biopharmaceuticals operates in the Health & Wellness sector.
When did Clover Biopharmaceuticals complete a stock split?▼
Clover Biopharmaceuticals has not had any recent stock splits.
Where is Clover Biopharmaceuticals headquartered?▼
Clover Biopharmaceuticals is headquartered in Shanghai, China.